|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 241 out of 241 for Tnfrsf4

<< First    < Previous  |  Next >    Last >>
0.019s
Type Details Score
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Allele
Name: transgene insertion 1, Nigel Killeen
Allele Type: Transgenic
Attribute String: Recombinase
Allele
Name: tumor necrosis factor receptor superfamily, member 4; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
DO Term
Allele
Name: tumor necrosis factor receptor superfamily, member 4; targeted mutation 1, Nigel Killeen
Allele Type: Targeted
Attribute String: Null/knockout
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tnfrsf4-cre)1Nik/?
Background: B6.129-Tnfrsf4 Gt(ROSA)26Sor
Zygosity: cn
Has Mutant Allele: true
Strain
Attribute String: targeted mutation, mutant strain, congenic
Genotype
Symbol: Tnfrsf4/Tnfrsf4
Background: involves: 129S4/SvJae * C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Gata3/Gata3 Tg(Tnfrsf4-cre)1Nik/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Hosokawa H
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Gata3/Ruvbl2 complex regulates T helper 2 cell proliferation via repression of Cdkn2c expression.
Volume: 110
Issue: 46
Pages: 18626-31
Publication
First Author: Cunninghame Graham DS
Year: 2008
Journal: Nat Genet
Title: Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus.
Volume: 40
Issue: 1
Pages: 83-9
Protein Domain
Type: Family
Description: TNFSF4 (also known as OX40L) is a cytokine that binds to its unique receptor, TNFRSF4 [].Cytokines can be grouped into a family on the basis of sequence, functional and structural similarities [, , ]. Tumor necrosis factor (TNF) (also known as TNF-alpha or cachectin) is a monocyte-derived cytotoxin that has been implicated in tumour regression, septic shock and cachexia [, ]. The protein is synthesised as a prohormone with an unusually long and atypical signal sequence, which is absent from the mature secreted cytokine []. A short hydrophobic stretch of amino acids serves to anchor the prohormone in lipid bilayers []. Both the mature protein and a partially-processed form of the hormone are secreted after cleavage of the propeptide [].There are a number of different families of TNF, but all these cytokines seem to form homotrimeric (or heterotrimeric in the case of LT-alpha/beta) complexes that are recognised by their specific receptors.
Publication
First Author: Pai SY
Year: 2008
Journal: J Immunol
Title: Distinct structural requirements of GATA-3 for the regulation of thymocyte and Th2 cell differentiation.
Volume: 180
Issue: 2
Pages: 1050-9
Publication
First Author: Moncrieffe H
Year: 2008
Journal: Immunology
Title: The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.
Volume: 125
Issue: 4
Pages: 459-68
Publication  
First Author: Gough MJ
Year: 2009
Journal: Adv Exp Med Biol
Title: OX40 (CD134) and OX40L.
Volume: 647
Pages: 94-107
Publication
First Author: Sugamura K
Year: 2004
Journal: Nat Rev Immunol
Title: Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.
Volume: 4
Issue: 6
Pages: 420-31
Publication
First Author: Kawamata S
Year: 1998
Journal: J Biol Chem
Title: Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation.
Volume: 273
Issue: 10
Pages: 5808-14
Publication
First Author: Chua KH
Year: 2016
Journal: Int J Immunogenet
Title: TNFSF4 polymorphisms are associated with systemic lupus erythematosus in the Malaysian population.
Volume: 43
Issue: 5
Pages: 303-9
Protein Domain
Type: Domain
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4), also known as OX40, ACT35, CD134, IMD16 or TXGP1L, activates NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5 []. It also promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis []. It is primarily expressed on activated CD4+ and CD8+ T cells, where it is transiently expressed and upregulated on the most recently antigen-activated T cells within inflammatory lesions. This makes it an attractive target to modulate immune responses, i.e. TNFRSF4 (OX40) blocking agents to inhibit adverse inflammation or agonists to enhance immune responses [, ]. An artificially created biologic fusion protein, OX40-immunoglobulin (OX40-Ig), prevents OX40 from reaching the T-cell receptors, thus reducing the T-cell response. Some single nucleotide polymorphisms (SNPs) of its natural ligand OX40 ligand (OX40L, CD252), which is also found on activated T cells, have been associated with systemic lupus erythematosus [].This entry represents the N-terminal domain of TNFRSF4. TNF-receptors are modular proteins. The N-terminal extracellular part contains a cysteine-rich region responsible for ligand-binding. This region is composed of small modules of about 40 residues containing 6 conserved cysteines; the number of modules can vary in number and type in different members of the family [, , ].
Publication
First Author: Zhu J
Year: 2004
Journal: Nat Immunol
Title: Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses.
Volume: 5
Issue: 11
Pages: 1157-65
Publication
First Author: Fu G
Year: 2021
Journal: Nature
Title: Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine.
Volume: 595
Issue: 7869
Pages: 724-729
Publication
First Author: Ciucci T
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cells.
Volume: 114
Issue: 50
Pages: 13236-13241
Publication
First Author: Wohlfert EA
Year: 2011
Journal: J Clin Invest
Title: GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice.
Volume: 121
Issue: 11
Pages: 4503-15
Protein
Organism: Mus musculus/domesticus
Length: 272  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 272  
Fragment?: false
Publication
First Author: Vacchio MS
Year: 2019
Journal: Immunity
Title: A Thpok-Directed Transcriptional Circuitry Promotes Bcl6 and Maf Expression to Orchestrate T Follicular Helper Differentiation.
Volume: 51
Issue: 3
Pages: 465-478.e6
Publication
First Author: Ciucci T
Year: 2019
Journal: Immunity
Title: The Emergence and Functional Fitness of Memory CD4+ T Cells Require the Transcription Factor Thpok.
Volume: 50
Issue: 1
Pages: 91-105.e4
Protein
Organism: Mus musculus/domesticus
Length: 198  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 198  
Fragment?: false
Publication
First Author: Farrah T
Year: 1992
Journal: Nature
Title: Emerging cytokine family.
Volume: 358
Issue: 6381
Pages: 26
Publication
First Author: Peitsch MC
Year: 1993
Journal: Int Immunol
Title: A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors.
Volume: 5
Issue: 2
Pages: 233-8
Publication
First Author: Fransen L
Year: 1985
Journal: Nucleic Acids Res
Title: Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.
Volume: 13
Issue: 12
Pages: 4417-29
Publication
First Author: Cseh K
Year: 1989
Journal: J Biol Chem
Title: Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein.
Volume: 264
Issue: 27
Pages: 16256-60
Publication
First Author: Sherry B
Year: 1990
Journal: Biochem Biophys Res Commun
Title: Characterization of high molecular weight glycosylated forms of murine tumor necrosis factor.
Volume: 173
Issue: 3
Pages: 1072-8
Publication
First Author: Kriegler M
Year: 1988
Journal: Cell
Title: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.
Volume: 53
Issue: 1
Pages: 45-53
Publication
First Author: Bazan JF
Year: 1993
Journal: Curr Biol
Title: Emerging families of cytokines and receptors.
Volume: 3
Issue: 9
Pages: 603-6
Publication
First Author: Naismith JH
Year: 1998
Journal: Trends Biochem Sci
Title: Modularity in the TNF-receptor family.
Volume: 23
Issue: 2
Pages: 74-9
Publication
First Author: Bodmer JL
Year: 2002
Journal: Trends Biochem Sci
Title: The molecular architecture of the TNF superfamily.
Volume: 27
Issue: 1
Pages: 19-26
Publication
First Author: Banner DW
Year: 1993
Journal: Cell
Title: Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.
Volume: 73
Issue: 3
Pages: 431-45